Medical Devices Market
PRODUCT TITLE | PUBLISHED | |
---|---|---|
Blood pressure monitors The “Global Blood pressure monitors Market”, mainly driven by increase chronically ill population, was pegged at $ 1.3 billion in 2012 and expected to be $ 2 billion by 2020, growing at a CAGR of 5.3%. The market has 2 segments such as Aneroid and Digital monitors. The key players are Omron Healthcare (Japan) (which holds around 50% share); the other major players are Microlife (Switzerland) and A&D Medical (U.S.). |
Upcoming | |
Blood cholesterol monitors Blood cholesterol monitors and Blood glucose monitors, |
Upcoming | |
Blood gas monitors The global Blood gas and electrolyte analyzers market is driven by inadequacy of alternate techniques. The market value was estimated $434 million in 2012 and is expected to reach $570 million by 2018, at a CAGR of 4.6%. The market is segmented into monitors such as Portable and Desktop. The key players of the market covered in this report are Roche, Siemens, Abbott and Bayer Healthcare. |
Upcoming | |
Low acuity Low acuity and Mid acuity and High acuity adds up to total |
Upcoming | |
Mid acuity Mid acuity and Low acuity and High acuity adds up to total |
Upcoming | |
High acuity High acuity and Low acuity and Mid acuity adds up to total |
Upcoming | |
Defibrillators The Global Defibrillators Market was pegged at $9.9 billion in 2013 and expected to be $13.4 billion by 2018, growing at a CAGR of 6.2%. The Global Defibrillators Market can be segmented by Submarkets,Geographies, Companies and MacroIndicators. Deep dive analysis of the key players of this market have been considered in this report. |
Upcoming | |
Analog Weight Monitors Analog Weight Monitors and Digital Weight Monitors adds up to total |
Upcoming | |
Digital Weight Monitors Digital Weight Monitors and Analog Weight Monitors adds up to total |
Upcoming | |
Surgical Automation The Global surgical automation Market, mainly driven by improved longevity, cost effectiveness, and an evolution that is attributed to the internet, was pegged at $3225.2 million in 2013 and expected to be $5426.7 million by 2018, growing at a CAGR of 11.0%. |
Upcoming | |
Immunohistochemistry Immunohistochemistry and Next Generation Sequencing (NGS) and |
Upcoming | |
Blood Blood and Hematology Cell Counters, Hematology Analyzers, Immuno Hematology, Hematology Reagents, Hematology Services, Hematology Rapid Testing and Hemostasis adds up to total |
Upcoming | |
Global Compact Advanced Radiotherapy Systems Market The Global Compact Advance Radiotherapy Systems Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $541 million in 2013 and expected to be $663 million by 2018, growing at a CAGR of 4.1%. The Compact Advance Radiotherapy Systems Market analyzes the market of devices by 3 segments such as Cyberknife, Gamma Knife, and TomoTherapy system.The prominent players in the Radiotherapy Devices Market globally areVarian Medical Systems, Elekta AB, Accuray Incorporation, Siemens, IBA S.A, covidien, Protom international Inc, Mevion Medical Systems, Inc. |
Upcoming | |
Global Proton Radiotherapy Systems Market The Global Proton Radiotherapy Systems Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $322 million in 2013 and expected to be $388 million by 2018, growing at a CAGR of 3.8%. The Proton Radiotherapy Systems Market analyzes the market of devices by 2 segments such as Cyclotron for proton therapy, and Synchrotron for proton therapy. The prominent players in the Radiotherapy Devices Market globally areVarian Medical Systems, Elekta AB, Accuray Incorporation, Siemens, IBA S.A, covidien, Protom international Inc, Mevion Medical Systems, Inc. |
Upcoming | |
Global Electron Emitting High Energy Linear Accelerators (Linac) Systems Market The Global High Energy Linear Accelerators(LINAC) Systems Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $3299 million in 2013 and expected to be $3769 million by 2018, growing at a CAGR of 2.7%. High Energy Linear Accelerators(LINAC) Systems Market analyzes the market of devices by segments by technology such as IMRT, IGRT, stereotactic, adaptive radiation therapy, volumetric modulated arc therapy and others. The prominent players in the Radiotherapy Devices Market globally areVarian Medical Systems, Elekta AB, Accuray Incorporation, Siemens, IBA S.A, covidien, Protom international Inc, Mevion Medical Systems, Inc. |
Upcoming | |
Global Brachytherapy Seeds Market The Global Brachytherapy Seeds Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $251.4 million in 2013 and expected to be $283.8 million by 2018, growing at a CAGR of 2.5%. The Brachytherapy Seeds Market analyzes the market of devices by segments such as Cesium-131, Iodine-125, Palladium-103, Iridium-192, and Other Seed Market. The prominent players in Brachytherapy Seeds Market globally are Elekta AB, Theragenics corp., C.R. Bard, Eckert & Ziegler BEBIG SA. |
Upcoming | |
Applicators & Afterloaders Applicators & Afterloaders and Brachytherapy Seeds and |
Upcoming | |
Electronic Brachytherapy Electronic Brachytherapy and Brachytherapy Seeds and |
Upcoming | |
Sleep Apnea Diagnostic Devices The Global Sleep Apnea Diagnostic Devices market has been on a rise as a consequence of elevated level of awareness of Sleep Apnea. The market is clinched at $3.6 billion in 2013 and is expected to reach a value of $7.3 billion in 2018, with a CAGR of 15.0% from 2013-2018. The market has been segmented on the basis of Products, Geographies, Endusers, Companies and Macroindicator. Deep dive analysis of the key players have been considered in this report. |
Upcoming | |
Sleep Apnea Therapeutic Devices The Global Sleep Apnea Therapeutic Devices market has been on a rise as a consequence of elevated level of awareness of Sleep Apnea. The market is clinched at $7.0 billion in 2013 and is expected to reach a value of $15.3 billion in 2018, with a CAGR of 17.0% from 2013-2018. The market has been segmented on the basis of Products, Geographies, Endusers, Companies and Macroindicator. Deep dive analysis of the key players have been considered in this report. |
Upcoming |
infertility Treatment